Company Active LTD

Company profile

Kromek Limited

Home - Kromek

Kromek Group plc supplies and develops radiation detection solutions based on cadmium zinc telluride (CZT) and other material, for applications within the medical imaging, civil nuclear, security screening and homeland security markets. We also work with OEMs, govts and other agencies to design and build new solutions.

CRN
04728565
Founded
2003
Age
23

Overview

Legal name
KROMEK LIMITED
Region
North East England
Registered address
NET PARK
THOMAS WRIGHT WAY
SEDGEFIELD
TS21 3FD
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller Controls 1
1
Company Active LTD
Kromek Limited
CRN 04728565
2
Direct and ultimate controller Active PLC
Kromek Group PLC
CRN 08661469

Company events

Reference milestones and recent Companies House filing stream events.

6 events
23 Apr
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Jan
2027

Accounts due

Accounts Due

Next accounts due date

09 Apr
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Apr
2025

Accounts filed

Accounts

Last accounts made up date

04 Nov
2024

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzQ0MTg4NDY3NGFkaXF6a2N4 | Paper/PDF filed

Published 05 Nov 2024 07:14

09 Apr
2003

Incorporated

Inception

Company registered at Companies House

Public funding

16 awards
First funded
2012
Funded years
2012, 2014, 2015, 2017, 2018, 2020, 2021, 2022, 2023, 2024
Age at first award
9 years

Projects

2024 EU-Funded Lead participant

Intelligent Radiation Sensor Readout System

1 Mar 2024 to 29 Feb 2028

Awarded
£1,295,131
Total cost £1,295,131

The vision of i-RASE is to pioneer a new class of radiation sensor system-in-package (SIP) chips at the intersection of computer scienceand neuroscience-oriented approaches to artificial intelligence (AI) development. The i-RASE project aims to design, build, test, and implement the first on-the-fly photon-by-photon radiation detector with transformationa...

2023 Collaborative R&D Lead participant

Low Dose Molecular Breast Imaging for Breast Cancer Detection

1 Jan 2023 to 31 Dec 2025

Awarded
£734,068
Total cost £1,223,446

Kromek are developing a Low Dose Molecular Breast Imaging Technology, which can solve the problem of the low sensitivity of mammography in dense breasts. The project, in collaboration with NUTH, Newcastle University and UCL, will continue the development and collect data critical to the adoption of the technology.

2022 Collaborative R&D Lead participant

Single photon detection for ultra-low dose Molecular Breast Imaging

1 Oct 2022 to 31 Mar 2024

Awarded
£298,816
Total cost £498,026

Breast screening was introduced in the UK almost 30 years ago and relies principally on x-ray mammography. This technique is effective where there is a significant difference in the density of a cancer tumor and the surrounding breast tissue. Around a third of women have denser breast tissue, such that mammography is unable to clearly image tumors, result...

2021 Collaborative R&D Lead participant

Resilience for "Automated detection of airborne SARS-CoV-2"

1 Dec 2021 to 31 Jan 2022

Awarded
£39,661
Total cost £39,661

In the Innovate Project "Automated detection of airborne SARS-CoV-2" we are developing a system to detect COVID in the air, to help fight the pandemic and prevent further outbreaks. This project is to provide resilience to this project against the effects of the pandemic on the project itself, by mitigating the effects of staff availability and resource c...

2020 Collaborative R&D Lead participant

Automated detection of airborne SARS-CoV-2

1 Dec 2020 to 31 May 2022

Awarded
£765,215
Total cost £1,275,358

The World Health Organisation has identified testing for the virus and tracing the contacts of those positive cases as critical to the control of the COVID-19 pandemic. The NHS Test & Trace system is a key tool to minimise the transmission of COVID in the population, and is critical to re-opening the economy. The current system receives information on peo...

2020 Collaborative R&D

Transforming Tissue Differentiation via Quantum Digital Tomosynthesis

1 Jul 2020 to 30 Jun 2023

Awarded
£466,433
Total cost £777,388

This application is about improving an existing medical imaging technique which is used during cancer surgery to distinguish between healthy and non-healthy tissue. The improvements will rely on the application of 'quantum technology'. Pathology is the study and diagnosis of disease through examination of surgically removed organs, tissues (biopsy samples...

2020 Feasibility Studies Lead participant

Continuity grant for Low Dose Molecular Breast Imaging

1 Jun 2020 to 31 Mar 2021

Awarded
£250,000
Total cost £250,000

no public description

2018 EU-Funded Lead participant

CZT Strip Drift Detectors for 3D Molecular Breast Imaging

1 Oct 2018 to 31 Jan 2021

Awarded
£320,768
Total cost £534,613

3D-MBI aims to deliver a disruptive Molecular Breast Imaging (MBI) device for breast cancer diagnosis, based on cadmium zinc telluride (CZT) strip drift detectors (DTU’s patented technology). 3D-MBI will bring disruptive performance to the MBI field through high tumour detection sensitivity, combined with 3D positional information– opening possibilities f...

2018 Collaborative R&D Lead participant

Low Dose Molecular Breast Imaging

1 Aug 2018 to 31 Mar 2022

Awarded
£682,415
Total cost £1,137,357

"Breast screening was introduced in the UK almost 30 years ago, and relies principally on x-ray mammography. This technique is effective where there is a significant difference in the density of a cancer tumor and the surrounding breast tissue. Around a third of women have denser breast tissue, such that mammography is unable to clearly image tumors, resu...

2017 Collaborative R&D Lead participant

Digital Single Photon Sensors to Enable a Step change in Civil Radiation Detection

1 Dec 2017 to 31 Mar 2021

Awarded
£336,588
Total cost £560,980

There is a growing concern over the risk of detonation of a radiological device, such as a "dirty bomb" in a major western city. Kromek supplies handheld radiation detectors to the US Government as part of their programme to build a capability to find such threats. In order to develop its devices to meet emerging requirements for this application, Kromek ...

2017 Study Lead participant

Kromek Design Led Innovation Programme

1 Jul 2017 to 31 Mar 2018

Awarded
£50,348
Total cost £83,913

The project will help Kromek embark on a process of learning to acquire and apply advanced ‘early stage design’ mindsets & skillsets in order to inform and improve future products, which we will add to our portfolio of detection devices for our markets. The application of this new approach will ensure that we champion the creation of significant and genui...

2017 Collaborative R&D Lead participant

Quantum Entanglement Tomography for enhanced medical imaging

1 Apr 2017 to 30 Jun 2019

Awarded
£286,238
Total cost £477,064

This proposal presents Quantum Entanglement Tomography (QET) as a technique which utilises the quantum entanglement of photon pairs to create a low noise imaging technology. When a positron annihilates with an electron, two photons of equal energy are emitted in approximately opposite directions. Positron Emission Tomography (PET) imaging determines the p...

Product types

Collaborative R&D EU-Funded Feasibility Studies Study